Literature DB >> 2426571

Expression of the mammalian c-fes protein in hematopoietic cells and identification of a distinct fes-related protein.

I MacDonald, J Levy, T Pawson.   

Abstract

The avian c-fps and mammalian c-fes proto-oncogenes are cognate cellular sequences. Antiserum raised against the P140gag-fps transforming protein of Fujinami avian sarcoma virus specifically recognized a 92,000-Mr protein in human and mouse hematopoietic cells which was closely related in structure to Snyder-Theilen feline sarcoma virus P87gag-fes. This polypeptide was apparently the product of the human c-fes gene and was therefore designated p92c-fes. Human p92c-fes was associated with a tyrosine-specific protein kinase activity in vitro and was capable of both autophosphorylation and phosphorylation of enolase as an exogenous protein substrate. The synthesis of human and mouse p92c-fes was largely, though not entirely, confined to myeloid cells. p92c-fes was expressed to relatively high levels in a multipotential murine myeloid cell line, in more mature human and mouse granulocyte-macrophage progenitors, and in differentiated macrophage like cells as well as in the mononuclear fraction of normal and leukemic human peripheral blood. p92c-fes was not found in erythroid cells, with the exception of a human erythroleukemia line which retains the capacity to differentiate into macrophage like cells. These results suggest a normal role for the p92c-fes tyrosine kinase in hematopoiesis, particularly in granulocyte-macrophage differentiation. In addition, a distinct 94,000-Mr polypeptide, antigenically related to p92c-fes, was identified in a number of hematopoietic and nonhematopoietic human and mouse cells and was also found to be associated with a tyrosine-specific protein kinase activity.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2426571      PMCID: PMC366988          DOI: 10.1128/mcb.5.10.2543-2551.1985

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  60 in total

1.  Acute myelogenous leukemia: a human cell line responsive to colony-stimulating activity.

Authors:  H P Koeffler; D W Golde
Journal:  Science       Date:  1978-06-09       Impact factor: 47.728

Review 2.  Biology of the human malignant lymphomas. IV. Functional characterization of ten diffuse histiocytic lymphoma cell lines.

Authors:  A L Epstein; R Levy; H Kim; W Henle; G Henle; H S Kaplan
Journal:  Cancer       Date:  1978-11       Impact factor: 6.860

3.  Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture.

Authors:  S J Collins; R C Gallo; R E Gallagher
Journal:  Nature       Date:  1977-11-24       Impact factor: 49.962

4.  Rosette-forming human lymphoid cell lines. I. Establishment and evidence for origin of thymus-derived lymphocytes.

Authors:  J Minowada; T Onuma; G E Moore
Journal:  J Natl Cancer Inst       Date:  1972-09       Impact factor: 13.506

5.  Hemoglobin synthesis in murine virus-induced leukemic cells in vitro: stimulation of erythroid differentiation by dimethyl sulfoxide.

Authors:  C Friend; W Scher; J G Holland; T Sato
Journal:  Proc Natl Acad Sci U S A       Date:  1971-02       Impact factor: 11.205

6.  Fusion between immunoglobulin-secreting and nonsecreting myeloma cell lines.

Authors:  G Köhler; S C Howe; C Milstein
Journal:  Eur J Immunol       Date:  1976-04       Impact factor: 5.532

7.  Clonal analysis of differentiated function in animal cell cultures. I. Possible correlated maintenance of differentiated function and the diploid karyotype.

Authors:  Y Yasumura; V Buonassisi; G Sato
Journal:  Cancer Res       Date:  1966-03       Impact factor: 12.701

8.  Monocyte function in man.

Authors:  M C Territo; M J Cline
Journal:  J Immunol       Date:  1977-01       Impact factor: 5.422

9.  Autocrine growth induced by src-related oncogenes in transformed chicken myeloid cells.

Authors:  B Adkins; A Leutz; T Graf
Journal:  Cell       Date:  1984-12       Impact factor: 41.582

10.  Fujinami sarcoma virus: an avian RNA tumor virus with a unique transforming gene.

Authors:  W H Lee; K Bister; A Pawson; T Robins; C Moscovici; P H Duesberg
Journal:  Proc Natl Acad Sci U S A       Date:  1980-04       Impact factor: 11.205

View more
  37 in total

1.  Regulation of c-Fes tyrosine kinase and biological activities by N-terminal coiled-coil oligomerization domains.

Authors:  H Cheng; J A Rogers; N A Dunham; T E Smithgall
Journal:  Mol Cell Biol       Date:  1999-12       Impact factor: 4.272

2.  Activated Fes protein tyrosine kinase induces terminal macrophage differentiation of myeloid progenitors (U937 cells) and activation of the transcription factor PU.1.

Authors:  Jynho Kim; Ricardo A Feldman
Journal:  Mol Cell Biol       Date:  2002-03       Impact factor: 4.272

3.  Development and characterization of a panel of monoclonal antibodies against the catalytic domain of the human fes proto-oncogene product.

Authors:  A van Bokhoven; H L van Duijnhoven; M Jücker; A J Roebroek; W J van de Ven
Journal:  Mol Biol Rep       Date:  1992-02       Impact factor: 2.316

4.  A highly efficient retroviral vector allows detection of the transforming activity of the human c-fps/fes proto-oncogene.

Authors:  R A Feldman; D R Lowy; W C Vass; T J Velu
Journal:  J Virol       Date:  1989-12       Impact factor: 5.103

5.  fur gene expression as a discriminating marker for small cell and nonsmall cell lung carcinomas.

Authors:  J A Schalken; A J Roebroek; P P Oomen; S S Wagenaar; F M Debruyne; H P Bloemers; W J Van de Ven
Journal:  J Clin Invest       Date:  1987-12       Impact factor: 14.808

6.  The KRAB-associated co-repressor KAP-1 is a coiled-coil binding partner, substrate and activator of the c-Fes protein tyrosine kinase.

Authors:  Frank J Delfino; Jonathan M Shaffer; Thomas E Smithgall
Journal:  Biochem J       Date:  2006-10-01       Impact factor: 3.857

7.  Expression, purification and preliminary crystallographic studies on the catalytic region of the nonreceptor tyrosine kinase Fes.

Authors:  Ilaria Gnemmi; Claudia Scotti; Donata Cappelletti; Pier Luigi Canonico; Fabrizio Condorelli; Camillo Rosano
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2006-12-16

8.  The Fps/Fes kinase regulates leucocyte recruitment and extravasation during inflammation.

Authors:  Sean A Parsons; Jeffrey D Mewburn; Peter Truesdell; Peter A Greer
Journal:  Immunology       Date:  2007-07-11       Impact factor: 7.397

9.  Nuclear and cytoplasmic location of the FER tyrosine kinase.

Authors:  Q L Hao; D K Ferris; G White; N Heisterkamp; J Groffen
Journal:  Mol Cell Biol       Date:  1991-02       Impact factor: 4.272

10.  A 41-kilodalton protein is a potential substrate for the p210bcr-abl protein-tyrosine kinase in chronic myelogenous leukemia cells.

Authors:  E Freed; T Hunter
Journal:  Mol Cell Biol       Date:  1992-03       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.